Login / Signup

Targeting formyl peptide receptor 1 by anteiso-C13-surfactin for neutrophil-dominant acute respiratory distress syndrome.

Shun-Chin YangYi-Hsuan WangChiu-Ming HoYung-Fong TsaiPing-Jyun SungTony Eight LinTsong-Long Hwang
Published in: British journal of pharmacology (2023)
IA-1 serves as the therapeutics for treating ARDS by inhibiting FPR1-mediated neutrophilic injury.
Keyphrases
  • acute respiratory distress syndrome
  • extracorporeal membrane oxygenation
  • mechanical ventilation
  • signaling pathway
  • small molecule
  • cancer therapy
  • bacillus subtilis